We have located links that may give you full text access.
Triple Phase CT May Replace Dual-energy X-ray Absorptiometry Scan For Evaluation of Osteoporosis in Liver Transplant Candidates.
Liver Transplantation 2020 October 24
BACKGROUND: Assessment of bone density is an important part of liver transplant (LT) evaluation for early identification and treatment of osteoporosis (OP). Dual-energy X-ray absorptiometry (DXA) is currently the standard clinical test for osteoporosis; however, it may contribute to the appointment burden on LT candidates during the cumbersome evaluation process and there are limitations affecting its accuracy. In this study, we evaluate the utility of biomechanical analysis of vertebral images obtained during triple phase dual-energy abdominal CT (TPCT) in diagnosing osteoporosis among LT candidates.
METHODS: Retrospective review of cases evaluated for liver transplant between 01/2017 and 03/2018. All patients who underwent dual-energy TPCT within 3 months of DXA were included. The biomechanical CT (BCT) analysis was performed at a centralized lab (O.N. Diagnostics, Berkeley, CA, USA), blinded to the DXA data. DXA-based osteoporosis was defined as T-score ≤ -2.5 at the hip or spine. BCT-based osteoporosis was defined as vertebral strength ≤ 4,500 N women or ≤ 6,500 N men, or trabecular volumetric bone mineral density ≤ 80 mg/cm3 .
RESULTS: Comparative data were available for 91 patients who had complete data for both DXA and BCT: (31 women, 60 men), mean (± SD) age 54 ± 11 years, mean body mass index 28 ± 6 kg/m2 . Using DXA as clinical reference, sensitivity of BCT to detect DXA-defined osteoporosis was 83.3% (20/24 patients) and negative predictive value was 91.7%; specificity and positive predictive value were 65.7%, 46.5%, respectively.
CONCLUSION: Biomechanical CT analysis of vertebral images on triple phase CT, routinely obtained during transplant evaluation, can reliably rule out osteoporosis in liver transplant candidates. Patients with suspicion of osteoporosis on TPCT may need further evaluation by DXA.
METHODS: Retrospective review of cases evaluated for liver transplant between 01/2017 and 03/2018. All patients who underwent dual-energy TPCT within 3 months of DXA were included. The biomechanical CT (BCT) analysis was performed at a centralized lab (O.N. Diagnostics, Berkeley, CA, USA), blinded to the DXA data. DXA-based osteoporosis was defined as T-score ≤ -2.5 at the hip or spine. BCT-based osteoporosis was defined as vertebral strength ≤ 4,500 N women or ≤ 6,500 N men, or trabecular volumetric bone mineral density ≤ 80 mg/cm3 .
RESULTS: Comparative data were available for 91 patients who had complete data for both DXA and BCT: (31 women, 60 men), mean (± SD) age 54 ± 11 years, mean body mass index 28 ± 6 kg/m2 . Using DXA as clinical reference, sensitivity of BCT to detect DXA-defined osteoporosis was 83.3% (20/24 patients) and negative predictive value was 91.7%; specificity and positive predictive value were 65.7%, 46.5%, respectively.
CONCLUSION: Biomechanical CT analysis of vertebral images on triple phase CT, routinely obtained during transplant evaluation, can reliably rule out osteoporosis in liver transplant candidates. Patients with suspicion of osteoporosis on TPCT may need further evaluation by DXA.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app